Breast Milk Policy
Breastfeeding is a powerful intervention in the prevention of disease and promotion of health in both infant and mother in the short and long term.
Yet breastfeeding rates in the UK are among the lowest worldwide, resulting in increased preventable illnesses for children and mothers and substantial associated costs to the health service. Because infant feeding is socially patterned, low breastfeeding rates have a serious impact on inequalities in health.
The advantage of financial support (incentives) is its ability to attract and engage its target audience. The impact of financial support (incentives) to women for breastfeeding is a relatively unexplored area.
Further information about the benefits of breastfeeding, breastfeeding in the UK and the use of financial incentives is available at the links on the right of this page.
NOSH (NOurishing Start for Health)
The NPRI-funded NOSH (NOurishing Start for Health) study is testing the feasibility, acceptability and effectiveness (both clinical/public health and cost effectiveness) of offering financial support (vouchers) for breastfeeding in a few areas in South Yorkshire and Derbyshire which have low 6-8 breastfeeding rates. It is hoped that offering vouchers to mothers will increase the prevalence and duration of breastfeeding.
The study has three stages, each with success criteria for progression to the next stage:
- A) Development Stage: developing the intervention (completed June 2013)
- B) Feasibility Stage: testing the feasibility and deliverability of the intervention (ongoing)
- C) Evaluation Stage: assessing the impact of the intervention using a cluster Randomised Controlled Trial and mixed methods process/context evaluation.
The results of this study will be used to inform commissioners and other public health decision makers as to the acceptability, feasibility and cost-effectiveness of behaviour change support in the form of vouchers to mothers to breastfeed in neighbourhoods with low breastfeeding rates. If effective, the intervention could have a major impact on the long-term health of the population, reducing the risk of disease in infancy, childhood, and adulthood.
Further information about the NOSH Scheme is available on the NOSH scheme website.
For more information, please contact:
Elaine Scott, the NOSH Study Manager: email@example.com or Tel.: 0114 222 4301